[
  {
    "ts": null,
    "headline": "The Cigna Group (NYSE:CI): Among the Cheap Stocks to Buy According to Billionaires",
    "summary": "We recently published a list of the 15 Best and Cheap Stocks to Buy According to Billionaires. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against the other cheap stocks held by billionaires. The S&P 500 index is trading around its all-time high, and the short-term […]",
    "url": "https://finnhub.io/api/news?id=1a8f11fc67b4e4159071f8ee2e8b0398f19e49555751b1953b72f5fd9f00d900",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742578503,
      "headline": "The Cigna Group (NYSE:CI): Among the Cheap Stocks to Buy According to Billionaires",
      "id": 133325688,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "We recently published a list of the 15 Best and Cheap Stocks to Buy According to Billionaires. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against the other cheap stocks held by billionaires. The S&P 500 index is trading around its all-time high, and the short-term […]",
      "url": "https://finnhub.io/api/news?id=1a8f11fc67b4e4159071f8ee2e8b0398f19e49555751b1953b72f5fd9f00d900"
    }
  },
  {
    "ts": null,
    "headline": "Cigna Group stock underperforms Friday when compared to competitors",
    "summary": "Cigna Group stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e86ac78fa8f1b442b0ac70e7fa66b2e9808be50c0fc03b75b50efc79ae3d35d5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742575200,
      "headline": "Cigna Group stock underperforms Friday when compared to competitors",
      "id": 133317638,
      "image": "",
      "related": "CI",
      "source": "MarketWatch",
      "summary": "Cigna Group stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e86ac78fa8f1b442b0ac70e7fa66b2e9808be50c0fc03b75b50efc79ae3d35d5"
    }
  },
  {
    "ts": null,
    "headline": "MDPL: No Reason To Pay Those Hefty Fees For Now",
    "summary": "Monarch Dividend Plus ETF holds a 30-stock portfolio focused on dividend growth. Click to see whether the MDPL ETF is worth the high fees that it charges.",
    "url": "https://finnhub.io/api/news?id=e190a321677a6e995cbdfbd70ffb28bfc381ae3e019d6d0c2da74065cfc3f916",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742571702,
      "headline": "MDPL: No Reason To Pay Those Hefty Fees For Now",
      "id": 133308268,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2185637836/image_2185637836.jpg?io=getty-c-w1536",
      "related": "CI",
      "source": "SeekingAlpha",
      "summary": "Monarch Dividend Plus ETF holds a 30-stock portfolio focused on dividend growth. Click to see whether the MDPL ETF is worth the high fees that it charges.",
      "url": "https://finnhub.io/api/news?id=e190a321677a6e995cbdfbd70ffb28bfc381ae3e019d6d0c2da74065cfc3f916"
    }
  },
  {
    "ts": null,
    "headline": "Q4 2024 ARS Pharmaceuticals Inc Earnings Call",
    "summary": "Q4 2024 ARS Pharmaceuticals Inc Earnings Call",
    "url": "https://finnhub.io/api/news?id=b06ae3467c635bb662b1d7d990e17f316f0105a5ac447e1c9243e27f8c1cd579",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742532039,
      "headline": "Q4 2024 ARS Pharmaceuticals Inc Earnings Call",
      "id": 133325689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Q4 2024 ARS Pharmaceuticals Inc Earnings Call",
      "url": "https://finnhub.io/api/news?id=b06ae3467c635bb662b1d7d990e17f316f0105a5ac447e1c9243e27f8c1cd579"
    }
  }
]